You are here

Cancer Imaging and Therapy Platform

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41CA213601-01
Agency Tracking Number: R41CA213601
Amount: $224,116.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: 102
Solicitation Number: PA15-270
Solicitation Year: 2016
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-09-20
Award End Date (Contract End Date): 2017-08-31
Small Business Information
Cleveland, OH 44143-2360
United States
DUNS: 192962061
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (216) 368-4099
Business Contact
Phone: (216) 373-1500
Research Institution

We will create a preclinical quantitative Cancer Imaging and Therapy Platform CITP which will allow one to
study cancer biology and optimize pipelines of technologies imaging agents imaging methods targeted nano
therapeutics tumor models etc especially for metastatic and invasive cancers Today primary tumor mass
es are clinically controlled with surgical drug and radiation therapies but the ability to control metastatic can
cer is limited and patients most often die from metastases Arguably metastatic cancer as the most important
front in the war on cancer but it is hampered by an inability to see the enemy Preclinical research on micro
metastases cell to mm and larger scattered throughout the body is limited because histology is impracti
cal and because traditional in vivo imaging has insufficient resolution and contrast for reliable detection CITP
will provide unique quantitative assessments for optimization of technologies targeting metastatic cancer The
central technology will be cryo imaging a section and image technique which provides anatomical color and
molecular fluorescence single cell sensitivity D microscopic imaging over vast volumes as large as an entire
mouse This will be linked via registration software to small animal medical imaging modalities PET MRI
SPECT fluorescence ultrasound etc and to histology The platform will include experimental methods small
animal imaging cryo imaging histology and software glue With visualization software a researcher will
zoom to a small GFP labeled tumor determine the presence of agent using highly sensitive cryo fluorescence
determine if there is detectable MR signal and optionally examine histology for target molecules Software will
also provide unique quantitative analyses CITP will add significant value to BioInVisionandapos s product line by
providing a quantitative platform for assessments and optimization of innovative cancer technologies Project Narrative
Although a primary tumor mass can be controlled the ability to control metastatic cancer is limited and patients
most often die from metastases We will create a unique preclinical quantitative Cancer Imaging and Therapy
Platform CITP suitable for the evaluation and optimization of pipelines of technologies imaging agents imag
ing methods therapeutics tumor models etc important for detecting understanding and treating metastatic
and invasive cancers

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government